Author

Tapan Mahendra Kadia

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-9892-9832Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Courtney Denton DinardoiD· 2 shared Farhad RavandiiD· 2 shared Sanam LoghaviiD· 2 shared Andrea LagansoniD· 1 shared Andrew J. CarrolliD· 1 shared Andrew R. StiffiD· 1 shared Angus Groom· 1 shared Ann‐Kathrin EisfeldiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Courtney Denton DinardoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Prognostic and Therapeutic Implications of BRAF Mutations in Acute Myeloid Leukemia

Darren Lee, Yazan Abu-Shihab, Kate Plas, Deedra Nicolet, Krzysztof Mrózek, Mark J. Routbort, Keyur Pravinchandra Patel, Christopher James Walker, Jill L. Buss, Andrew R. Stiff, Andrea Laganson, Courtney Denton Dinardo, Naval Guastad Daver, Tapan Mahendra Kadia, Farhad Ravandi, , Linde A. Miles

This study identifies BRAF mutations in AML, showing poor outcomes and unique co-mutation patterns, suggesting potential targeted therapies.

Leukemia · Jun 15, 2026Peer-reviewedCancer Biology

Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy

Sven Turkalj, Bilyana Stoilova, Angus Groom, Felix A. Radtke, Rabea Mecklenbrauck, Niels Asger Jakobsen, Curtis Andrew Lachowiez, Marlen Metzner, Batchimeg Usukhbayar, Mirian Angulo Salazar, Zhihong Zeng, Sanam Loghavi, Jennifer Marvin‐Peek, Verena Körber, Farhad Ravandi, , Paresh Vyas

This study shows that resistant clones are rapidly selected in hematopoietic cell compartments with leukemic stem cell potential before relapse in patients treated with ivosidenib combination therapy.

Blood · Nov 5, 2025Peer-reviewedCancer Biology